Sparsentan | m-entrepreneurship.com

Product Name :
Sparsentan

Search keywords :
Sparsentan

drugId :
null

Target Vo:
Endothelin receptor type A

Target Vo Short Name :
ETAR

Moa_Name:
Angiotensin II Receptor Type 1 antagonists

First Approval Country :
United States

First Approval Date Filter:
2023

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :
Renalys Pharma Inc

Active Indication_Name:
Glomerulonephritis, IGA

In Active Indication_Name:
Hypertension

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Gemtuzumab manufacturer
alpha Tubulin Rabbit mAb manufacturer
beta Tubulin Antibody: beta Tubulin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to beta Tubulin. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts